r&d (research and development)

  1. S

    ZeroHarm Sciences Expands with Investment in Measurable Health Outcomes

    Hyderabad, February 25 ZeroHarm Sciences, a nano-formulated, plant-based nutraceutical brand, announced on Wednesday that it has raised ₹65 crore from Kotak Life Sciences Fund and Alkemi Growth Capital.Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I...
    • Somya
    • News
    • alkemi growth capital consumer wellness diagnostic testing health platform healthcare hyderabad india investment funding kotak life sciences fund manufacturing nanotechnology nutraceuticals plant-based supplements r&d (research and development) zeroharm sciences
    • Replies: 0
    • Forum: Business
Back
Top